Thursday 18 November:
|
| 14.00–14.45
|
Welcome
|
| 14.45–15.00
|
Introduction |
| Session
1: |
General Aspects of Connective Tissue Remodelling |
| 15.00–15.30
|
Robert A. BROWN
(Stanmore, UK): ‘Cytomechanics in tissue repair engineering’ |
| 15.30–16.00
|
Galina S. BOGATKEVICH
(Charleston, USA): ‘Scleroderma lung fibroblasts: contractility
and its basis’ |
| 16.00–16.30
|
Richard P. PHIPPS
(Rochester NY, USA): ‘Fibroblast diversity: Thy 1 and other
markers to define fibroblast subsets’ |
| 16.30–17.00
|
Coffee
break |
| 17.00–18.00
|
Short communications
(3) |
| 18.00–19.00
|
Poster |
| 19.30
|
Dinner |
| |
|
Friday
19 November:
|
| Session
2: |
Origin
of the Myofibroblast |
| 09.00–09.30
|
Sabrina MATTOLI
(Basel, Switzerland): ‘Tissue repair in asthma: the origin of
airway subepithelial fibroblasts and myofibroblasts’ |
| 09.30–10.00
|
Raghu KALLURI
(Boston, USA): ‘Epithelial to mesenchymal transition is a key
contributor to organ fibrosis’ |
| 10.00–10.30
|
Manuel LOPEZ-CABRERA
(Madrid, Spain): ‘Epithelial-mesenchymal transition of mesothelial
cells as a pathophysiologic response to peritoneal dialysis’
|
| 10.30–11.00
|
Coffee
break |
| 11.00–12.00
|
Short communications
(3) |
| 12.00–14.00
|
Lunch |
| 14.00–15.00 |
Poster |
| Session
3: |
Interactions
of Myofibroblasts with Other Cells |
| 15.00–15.30 |
Sem H. PHAN
(Ann Arbor, USA): ‘FIZZy alveoar epithelial cells induce myofibroblast
differentiation’ |
| 15.30–16.00
|
Marc MAREEL (Gent,
Belgium): ‘Molecular cross-signaling between myofibroblasts
and cancer cells stimulates invasion of both’ |
| 16.00–16.30
|
Fernando VIDAL-VANACLOCHA
(Leioa, Bizkaia, Spain): ‘Proangiogenic implications of hepatic
stellate cell transformation into myofibroblasts by tumor microenvironment’ |
| 16.30–17.00
|
Coffee
break |
| 17.00–18.00
|
Short communications
(3) |
| 18.30
… |
Banquet |
| |
|
Saturday
20 November:
|
| Session
4: |
Organ
Fibrosis |
| 09.00–09.30
|
John P. IREDALE
(Southampton, UK): ‘MMPs, TIMPs and matrix turnover and the
fate of hepatic stellate cells’ |
| 09.30–10.00
|
Paul W. NOBLE
(New Haven, USA): ‘Innate immune regulation of lung inflammation
and fibrosis’ |
| 10.00–10.30
|
James V. JESTER
(Dallas, USA): ‘An eye on repair’ |
| 10.30–11.00
|
Coffee
break |
| 11.00–12.00 |
Short communications
(3) |
| 12.00–12.15
|
Conclusions |
| 12.30
|
Lunch |
